Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

101.81
+3.053.09%
Post-market: 101.810.00000.00%17:54 EDT
Volume:978.27K
Turnover:99.26M
Market Cap:24.43B
PE:-35.50
High:102.99
Open:97.50
Low:97.30
Close:98.76
Loading ...

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

GuruFocus.com
·
1 hour ago

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
Yesterday

Press Release: Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank

Dow Jones
·
Yesterday

Private credit needs to lift its game to be taken seriously

The Australian Financial Review
·
Yesterday

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Motley Fool
·
19 Apr

Nexus AG Discloses Manager’s Share Sale

TIPRANKS
·
17 Apr

BioNTech Se : Leerink Partners Cuts Target Price to $112 From $121

THOMSON REUTERS
·
17 Apr

Bank of America Securities Remains a Buy on BioNTech SE (BNTX)

TIPRANKS
·
17 Apr

SAP SE (0NW4): New Buy Recommendation for This Technology Giant

TIPRANKS
·
17 Apr

Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula

Simply Wall St.
·
17 Apr

Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty

Benzinga
·
16 Apr

GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum

NewMediaWire
·
16 Apr

Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance

PR Newswire
·
16 Apr

Why Typhoid Trump and COVID are so similar

The Sydney Morning Herald
·
16 Apr

GeoVax received written notification from ATI to stop Phase 2 COVID-19 work

TIPRANKS
·
16 Apr

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live
·
16 Apr

Standard Chartered Bank Expects Stablecoin Total Supply to Skyrocket to $20 Trillion by 2028

Blockbeats
·
15 Apr

Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength?

Zacks
·
15 Apr

GeoVax to Present Clinical Data at Upcoming April Industry Events

NewMediaWire
·
15 Apr

Novavax Says COVID-19 Vaccine Induces Fewer Symptoms Compared With Pfizer's Vaccine

MT Newswires Live
·
15 Apr